Status | Study |
Completed |
Study Name: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2005-09-20 Interventions: Biological: anti-thymocyte globulin Biolog |
Terminated |
Study Name: Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2005-03-03 Interventions: Dietary Supplement: cholecalciferol |
Completed |
Study Name: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes Condition: Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Date: 2004-12-07 Interventions: Drug: amifostine trihydrate |
Completed |
Study Name: Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Condition: Leukemia Myeloproliferative Disorders Date: 2004-01-09 Interventions: Biological: Allogeneic bone marrow transplantation |
Terminated |
Study Name: Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) Condition: Acute Myelogenous Leukemia Chronic Myelomonocytic Leukemia Date: 2003-12-19 Interventions: Drug: DTGM Starting dose: 2 mcg/kg by vein three times a week (M,W,F) for two consecutive weeks. |
Completed |
Study Name: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2003-11-04 Interventions: Drug: vatalanib Pts registered before 1/15/05 1250 mg/day PO After 1/15/05: Start w/ 750 mg/day PO; esca |
Completed |
Study Name: Cholecalciferol in Treating Patients With Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2003-09-10 Interventions: Dietary Supplement: cholecalciferol |
Terminated |
Study Name: Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia Condition: Chronic Myeloproliferative Disorders Leukemia Myelodysplas Date: 2003-08-06 Interventions: Drug: cyclophosphamide Drug: cyclosporine |
Completed |
Study Name: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2003-07-08 Interventions: Drug: cytarabine Drug: triapine |
Completed |
Study Name: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders Condition: Leukemia Lymphoma Myelodysplastic Syndromes Date: 2003-03-06 Interventions: Biological: anti-thymocyte globulin Biolog |